Kevin C. Johnson is Director at NEOGENOMICS INC (NEO). They have made 5 open-market trades across 1 company since 2016, most recently 2021-12-22.
CIK 0001353436
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
2 open-market purchases totalling $451K since 2016, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| NEO | 37,398 | $623K |
Shares reported on the most recent Form 4, priced at the 2021-12-23 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| NEO | SELL | 2020-12-04 | 2020-12-07 | $47.88 | $2.4M | +8.9% | +4.4% | -15.5% |
| NEO | SELL | 2019-08-23 | 2019-08-27 | $25.41 | $1.3M | -7.3% | -20.1% | +4.4% |
| NEO | BUY | 2018-12-21 | 2018-12-26 | $11.60 | $302K | +8.2% | +36.8% | +59.6% |
| NEO | SELL | 2018-11-09 | 2018-11-13 | $17.03 | $2.2M | -0.1% | -18.6% | +1.3% |
| NEO | BUY | 2016-03-03 | 2016-03-07 | $6.78 | $149K | -13.4% | -3.8% | +23.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.